期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
多黏菌素B对脓毒症合并泛耐药革兰阴性菌感染患者的疗效 被引量:5
1
作者 贺黉裕 吴雪飞 +5 位作者 居旻杰 刘以梅 顾准咏 刘雯珺 苏迎 罗哲 《中国临床医学》 2021年第2期241-247,共7页
目的:评估脓毒症合并感染泛耐药(extensively drug-resistant,XDR)革兰阴性菌的患者使用多黏菌素B的疗效。方法:回顾性收集2018年8月至2019年7月重症监护室(ICU)收治的30例以多黏菌素B为基础联合抗感染治疗合并XDR脓毒症的数据。记录患... 目的:评估脓毒症合并感染泛耐药(extensively drug-resistant,XDR)革兰阴性菌的患者使用多黏菌素B的疗效。方法:回顾性收集2018年8月至2019年7月重症监护室(ICU)收治的30例以多黏菌素B为基础联合抗感染治疗合并XDR脓毒症的数据。记录患者临床特征,细菌感染的部位、种类,使用多黏菌素B的剂量、持续时间,多黏菌素B启动早晚(泛耐药菌培养阳性48 h以内或48 h以后使用多黏菌素B)。主要结局为患者在ICU中死亡。结果:共纳入30例患者,其中男性24例,平均年龄为(66.7±18.9)岁,均为多黏菌素B与广谱抗生素静脉联合用药。感染XDR革兰阴性菌患者包括感染肺炎克雷伯菌11例、感染鲍曼不动杆菌11例、感染铜绿假单胞菌3例,感染2种以上耐药菌5例。感染部位分别为血流(13例)、肺部(14例)和导管(3例)。14例(46.6%)患者48 h内启用多黏菌素B,使用多黏菌素B的中位时间为8 d,中位累计剂量为1115.0 mg。血流感染的细菌转阴率(76.9%)明显高于肺部感染(7.1%)和导管感染(66.7%,P=0.001)。ICU患者死亡率为60.0%(18/30)。多因素分析提示,序贯器官衰竭(SOFA)评分(OR=1.434,95%CI 1.017~2.022,P=0.040)和晚于48 h启用多黏菌素B(OR=12.950,95%CI 1.487~112.770,P=0.020)与ICU死亡密切相关。使用多黏菌素B前36.7%的患者存在慢性肾功能不全;使用多黏菌素B后,急性肾损伤(AKI)患者增至70.0%(χ2=4.27,P=0.039)。结论:对于合并感染XDR革兰阴性菌的脓毒症患者,晚启用多黏菌素B与不良预后相关;使用多黏菌素B后,需密切关注药物相关AKI。 展开更多
关键词 多黏菌素B 脓毒症 泛耐药 革兰阴性菌
下载PDF
Evaluation of acute kidney injury as defined by the risk, injury, failure, loss, and end-stage criteria in critically ill patients undergoing abdominal aortic aneurysm repair 被引量:4
2
作者 YUE Jia-ning LUO Zhe +11 位作者 GUO Da-qiao XU Xin CHEN Bin JIANG jun-hao YANG jue SHI Zhen-yu ZHU Ting ju min-jie TU Guo-wei WANG Yu-qi ZHU Du-ming FU Wei-guo 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第3期431-436,共6页
Background Acute kidney injury (AKI) is considered as a common and significant complication following abdominal aortic aneurysm (AAA) repair. This study aimed to assess the associated risk factors of AKI in the cr... Background Acute kidney injury (AKI) is considered as a common and significant complication following abdominal aortic aneurysm (AAA) repair. This study aimed to assess the associated risk factors of AKI in the critically ill patients undergoing AAA repair and to evaluate the appropriate AKI management in the specific population. Methods We retrospectively examined data from all critically ill patients undergoing AAA repairs at our institution from April 2007 to March 2012. Multivariable analysis was used to identify factors associated with postoperative AKI, which was defined by risk, injury, failure, loss and end-stage (RIFLE) kidney disease criteria. The goal-directed hemodynamic optimization (maintenance of optimal hemodynamics and neutral or negative fluid balance) and renal outcomes were also reviewed. Results Of the 71 patients enrolled, 32 (45.1%) developed AKI, with 30 (93.8%) cases diagnosed on admission to surgical intensive care unit (SICU). Risk factors for AKI were ruptured AAA (odds ratio (OR)=5.846, 95% confidence interval (CI): 1.346-25.390), intraoperative hypotension (OR=6.008, 95% CI: 1.176 to 30.683), and perioperative blood transfusion (OR=4.611, 95% CI: 1.307-16.276). Goal-directed hemodynamic optimization resulted in 75.0% complete and 18.8% partial renal recovery. Overall in-hospital mortality was 2.8%. AKI was associated with significantly increased length of stay ((136.9±24.5) hours vs. (70.4±11.3) hours) in Surgical Intensive Care Unit. Conclusions Critically ill patients undergoing AAA repair have a high incidence of AKI, which can be early recognized by RIFLE criteria. Rupture, hypotension, and blood transfusion are the significant associated risk factors. Application of goal-directed hemodynamic optimization in this cohort appeared to be effective in improving renal outcome. 展开更多
关键词 abdominal aortic aneurysm acute kidney injury risk injury failure loss and end-stage critical care goal-directed ENDOVASCULAR
原文传递
Predictive value of N-terminal pro-brain natriuretic peptide in combination with the sequential organ failure assessment score in sepsis 被引量:11
3
作者 ju min-jie ZHU Du-ming +4 位作者 TU Guo-wei HE Yi-zhou XUE Zhang-gang LUO Zhe WU Zhao-guang 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第11期1893-1898,共6页
Background The prognostic power of n-terminal pro-brain natriuretic peptide (NT-proBNP) in sepsis is disputable and unstable among different models. We attempt to evaluate the prognostic potential of NT-proBNP in co... Background The prognostic power of n-terminal pro-brain natriuretic peptide (NT-proBNP) in sepsis is disputable and unstable among different models. We attempt to evaluate the prognostic potential of NT-proBNP in combination with the sequential organ failure assessment (SOFA) score in sepsis. Methods In this retrospective study, 100 consecutive sepsis patients were enrolled. Clinical data such as admission SOFA, the Acute Physiologic and Chronic Health Evaluation score, shock prevalence, use of lung protective ventilation, vasopressors, and glucocorticoids were recorded. Additionally, serum creatinine (Scrl and Scr3) and NT-proBNP (NT-proBNP1 and NT-proBNP3) were assayed and evaluated at admission and on day 3 respectively. Results ANT-proBNP (NT-proBNP3 minus NT-proBNP1) (P 〈0.001, Hazard ratio (HR)=1.245, 95% confidence interval (CI), 1.137-1.362) and admission SOFA (P 〈0.001, HR=1.197, 95% CI, 1.106-1.295) were independently related to in-hospital mortality. Their combination was a more robust predictor for in-hospital mortality than either of them individually. Patients with high ANT-proBNP and SOFA had the poorest prognosis. Conclusions In our study, both ANT-proBNP and SOFA were independent predictors of septic patients' prognosis. Moreover, the combination of ,~NT-proBNP and admission SOFA provided a novel strategy that contained information regarding both the response to treatment and sepsis severity. 展开更多
关键词 SEPSIS PROGNOSIS N-terminal pro-brain natriuretic peptide sequential organ failure assessment score COMBINATION
原文传递
Antithymocyte globulin-induced acute respiratory distress syndrome after renal transplantation: a case report
4
作者 TU Guo-wei ju min-jie +3 位作者 XU Ming RONG Rui-ming ZHU Tong-yu LUO Zhe 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第9期1664-1666,共3页
Antithymocyte globulin (ATG) has long been used for immune-induction and anti-rejection treatments for solid organ transplantations. To date, few cases of ATG-induced acute respiratory distress syndrome (ARDS) hav... Antithymocyte globulin (ATG) has long been used for immune-induction and anti-rejection treatments for solid organ transplantations. To date, few cases of ATG-induced acute respiratory distress syndrome (ARDS) have been published. Here, we present a case of ARDS caused by a single low-dose of ATG in a renal transplant recipient and the subsequent treatments administered. Although the patient suffered from ARDS and delayed graft function, he was successfully treated. We emphasize that the presence of such complications should be considered when unexplained respiratory distress occurs. Early use of corticosteroids, adjustment of immunosuppressive regimens, and conservative fluid management, as well as empiric antimicrobial therapies, may be effective strategies for the treatment of ARDS caused by ATG. 展开更多
关键词 antithymocyte globulin acute respiratory distress syndrome renal transplantation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部